-
Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. DC CAFC
- 1:20-cv-00110
- N.D.W. Va.
- Filed: 06/09/2020
- Closed: 06/06/2022
- Latest Docket Entry: 06/10/2022
- Judge: John Preston Bailey
- PACER
1
Plaintiff
1
Defendant
2
Accused
Products
2
Patents-in-Suit
728
Days in
Litigation
-
Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. DC CAFC
- 1:20-cv-00110
- N.D.W. Va.
- Filed: 06/09/2020
- Closed: 06/06/2022
- Latest Docket Entry: 06/10/2022
- Judge: John Preston Bailey
- PACER
Cause of Action
Infringement
Market Sector
Biotech and Pharma
Assigned Judge
Outcome Summary
Patent Information
-
Infringement
Mylan Pharmaceuticals Incorporated
- 2 Details
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Generic Version epoprostenol sodium injection 0.5 mg/vialGeneric Version epoprostenol sodium injection 1.5 mg/vial | US 8,318,802 B2 |
1, 6, 8, 10, 11, 16, 18, 20, 22
|
Infringement
Entry 185
|
| Generic Version epoprostenol sodium injection 0.5 mg/vialGeneric Version epoprostenol sodium injection 1.5 mg/vial | US 8,598,227 B2 |
1, 2, 3, 8, 10, 12, 14, 16, 18, 19, 20, 21, 22, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42
|
Infringement
Entry 185
|